B
Biosergen AB
STO:BIOSGN
Biosergen AB
STO:BIOSGN
Price:
38.4
SEK
Market Closed
Market Cap:
kr90.2m
Income Statement
Earnings Waterfall
Biosergen AB
Biosergen AB
Income Statement
Biosergen AB
Biosergen AB
Currency: SEK
| Jun-2023 | Sep-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
(0)
N/A
|
(0)
-1%
|
(0)
+97%
|
(0)
+83%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(34)
|
(27)
|
(22)
|
(20)
|
(17)
|
(19)
|
(18)
|
(23)
|
(31)
|
|
| Selling, General & Administrative |
(7)
|
(8)
|
(7)
|
(8)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
|
| Other Operating Expenses |
(27)
|
(19)
|
(15)
|
(12)
|
(12)
|
(14)
|
(12)
|
(18)
|
(26)
|
|
| Operating Income |
(34)
N/A
|
(27)
+20%
|
(22)
+18%
|
(20)
+10%
|
(17)
+16%
|
(19)
-14%
|
(18)
+9%
|
(23)
-30%
|
(31)
-34%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(34)
N/A
|
(27)
+20%
|
(22)
+17%
|
(20)
+10%
|
(17)
+16%
|
(19)
-13%
|
(17)
+9%
|
(23)
-30%
|
(31)
-34%
|
|
| Net Income | ||||||||||
| Income from Continuing Operations |
(34)
|
(27)
|
(22)
|
(20)
|
(17)
|
(19)
|
(17)
|
(23)
|
(31)
|
|
| Net Income (Common) |
(34)
N/A
|
(27)
+20%
|
(22)
+17%
|
(20)
+10%
|
(17)
+16%
|
(19)
-13%
|
(17)
+9%
|
(23)
-30%
|
(31)
-34%
|
|
| EPS (Diluted) |
-47.56
N/A
|
-32.05
+33%
|
-26.16
+18%
|
-14.05
+46%
|
-11.73
+17%
|
-11.72
+0%
|
-7.43
+37%
|
-10.3
-39%
|
-13.02
-26%
|
|
Switch to:
Switch to:
See Also
Discover More
